MADHAVBAUG — Vaidya Sane Ayurved Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.75bn
- IN₹1.59bn
- IN₹898.47m
- 73
- 27
- 88
- 71
Annual cashflow statement for Vaidya Sane Ayurved Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 16.1 | 47.6 | 64.3 | 28.6 | 99 |
| Depreciation | |||||
| Non-Cash Items | 5.69 | 0.4 | -2.97 | -2 | 3.81 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.5 | -202 | -86.7 | -70.7 | -38.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 57.8 | -131 | 0.641 | -12.6 | 106 |
| Capital Expenditures | -6.81 | -31.7 | -69.8 | -112 | -84.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.71 | -45.4 | 75 | -18.4 | -16.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4.1 | -77.1 | 5.19 | -130 | -101 |
| Financing Cash Flow Items | -5.69 | 189 | -1.88 | -2.48 | -3.24 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -55.2 | 225 | -13.8 | 149 | -5.37 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.55 | 16.6 | -7.97 | 6.09 | -0.121 |